Keyword: CMI0324

Chemistry & Life Sciences

Uncovering Potential

11.09.2024 -

Interview with Olivier Lambrechts, executive leadership team member and president NCE at Arxada.

Chemistry & Life Sciences

Minicircle DNA

11.09.2024 -

The minicircle has emerged as a Next Generation Gene Vector and as a promising tool in the field of gene delivery and therapeutic applications. This overview aims to...

Strategy & Management

Pharma’s Digital Transformation

11.09.2024 -

Industry experts Michelangelo Canzoneri, Josef Trapl, Wolfgang Winter, Christian Woelbeling, and Thomas Zimmer – all members of ISPE’s Pharma 4.0 guide core team –...

Logistics & Supply Chain

Chemical Logistics Study 2024

11.09.2024 -

A study on logistics in the chemical industry shows that there is a significant need to develop a more professional approach to supply chain and logistics planning and...

Chemistry & Life Sciences

Expert Statement: Kenneth N. Drew, Flamma

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Chemistry & Life Sciences

Expert Statement: Alex Del Priore, Syngene

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Chemistry & Life Sciences

Expert Statement: Gordon Bates, Lonza

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

Chemistry & Life Sciences

Expert Statement: Greg Behar, Recipharm

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.